Pfizer’s eczema drug clears skin in mid-stage trial

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 01 Oct, 15:03 UTC

Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.

science

Sources

• T2Pfizer’s eczema drug clears skin in mid-stage trialBioPharma Dive / Healthcare Dive / MedTech Dive01 Oct, 15:03